Private pharmacies in tuberculosis control—a neglected link. Int J Tuberc Lung Dis 2002;6:171–3.
  • Lonnroth K, Lambregts K, Nhien DT, Quy HT, Diwan VK. Private pharmacies and tuberculosis control: A survey of case detection skills and reported anti-tuberculosis drug dispensing in private pharmacies in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2000;4:1052–9.
  • Liefooghe R, Muynck AD. The dynamics of tuberculosis treatment adherence. J Pak Med Assoc 2001;51:3–9.
  • Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V, Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000;47:27–33.
  • Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521–6.
  • The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Antituberculosis drug resistance in the world. Report no. 2: Prevalence and trends. Geneva:World Health Organization, 2000. WHO/CDS/TB/2000.278.
  • Gupta R, Kim JY, Espinal MA, Caudron JM, Pecoul B, Farmer PE, et al. Public health responding to market failures in tuberculosis control. Science 2001;293: 1049–51.
  • Sterling TR, Lehmann HP, Frieden TR. Impact of DOTS compared with DOTS-Plus on multidrug resistant tuberculosis and tuberculosis deaths: Decision analysis. BMJ 2003;326:574.

  • National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India
    T. N. Medical College, Mumbai Central, Mumbai 400008, Maharashtra, India
    URMILA THATTE Department of Clinical Pharmacology
    Correspondence to URMILA THATTE;


    NMJI Web
    Contact Us | Site Map | Feedback | Disclaimer © 2004 The National Medical Journal of India - All rights Reserved
    Powered by Logicsoft International Private Limited